What is Myriad Genetics's cash ratio?

Myriad Genetics (MYGN) reported cash ratio of 1× in Q1 2026.

How has Myriad Genetics's cash ratio changed year-over-year?

Myriad Genetics's cash ratio increased by 44.8% year-over-year, from 0.7× to 1×.

What is the long-term trend for Myriad Genetics's cash ratio?

Over 5 years (2020 to 2025), Myriad Genetics's cash ratio has grown at a 7.1% compound annual growth rate (CAGR), from 0.8× to 1.1×.

What does cash ratio mean?

Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.

Myriad Genetics MYGN Cash ratio

Cash ratio at other companies

Labcorp HoldingsLH

0.4×+0.2×

Quest DiagnosticsDGX

0.2×0.0×

NeoGenomicsNEO

1.7×+0.5×

VeracyteVCYT

4.7×+2.2×

Guardant HealthGH

3.8×+0.2×

Natera, Inc.NTRA

1.9×-0.7×

Other financials

Income statement

See full

Revenue$200.4M+2.3%

Gross profit$137.6M+2.5%

Operating income-$30.7M-5.9%

Net income-$34.1M-34,000%

EPS (diluted)-$0.36—

Balance sheet

See full

Cash & equivalents$126.0M+24.8%

Total debt$211.5M+34.2%

Total equity$337.4M-52.1%

Total assets$673.7M-33.0%

Cash flow

See full

Operating cash flow-$15.7M+3.7%

CapEx$18.8M+181%

Free cash flow-$19.7M+65.1%

Valuation

See full

Market cap$512.85M+13.1%

Enterprise value$598.35M+17.3%

P/S0.6×+0.1×

Profitability

See full

Gross margin70%0.0pp

Operating margin-46.9%-88.3pp

Net margin-48.2%-72.9pp

FCF margin-17%—

Returns & leverage

See full

Return on equity-76.7%-98.4pp

Debt / equity0.6×+0.4×

Current ratio2.4×+0.5×

Where this comes from

Calculated from Myriad Genetics’s reported figures.

cash and equivalents/total current liabilities=1×

Based on the most recent quarter.

The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Myriad Genetics's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Myriad Genetics's cash ratio?: Myriad Genetics (MYGN) reported cash ratio of 1× in Q1 2026.
How has Myriad Genetics's cash ratio changed year-over-year?: Myriad Genetics's cash ratio increased by 44.8% year-over-year, from 0.7× to 1×.
What is the long-term trend for Myriad Genetics's cash ratio?: Over 5 years (2020 to 2025), Myriad Genetics's cash ratio has grown at a 7.1% compound annual growth rate (CAGR), from 0.8× to 1.1×.
What does cash ratio mean?: Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.